Earnings Feed
Start Free
Home/Filings/4/0000899243-22-025698
4//SEC Filing

Urso David M 4

Accession 0000899243-22-025698

CIK 0001262104other
View on SEC.govCompany Profile

Filed

Jul 6, 8:00 PM ET

Accepted

Jul 7, 4:22 PM ET

Size

16.2 KB

Accession

0000899243-22-025698

Insider Transaction Report

Form 4
Period: 2022-07-05
MEI Pharma, Inc.MEIP
Urso David M
Sr. V.P. and General Counsel
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-07-05+1,050,000→ 1,050,000 total
    Exercise: $0.54Exp: 2032-07-05→ Common Stock (1,050,000 underlying)
Holdings

  • Stock Option (Right to Buy)

    Exercise: $4.33Exp: 2028-06-22→ Common Stock (130,000 underlying)
    130,000

  • Stock Option (Right to Buy)

    Exercise: $2.52Exp: 2029-07-01→ Common Stock (350,000 underlying)
    350,000

  • Stock Option (Right to Buy)

    Exercise: $3.49Exp: 2030-07-02→ Common Stock (525,000 underlying)
    525,000

  • Stock Option (Right to Buy)

    Exercise: $2.95Exp: 2031-07-01→ Common Stock (600,000 underlying)
    600,000

  • Stock Option (Right to Buy)

    Exercise: $1.57Exp: 2025-07-28→ Common Stock (127,500 underlying)
    127,500

  • Stock Option (Right to Buy)

    Exercise: $1.36Exp: 2026-07-29→ Common Stock (130,000 underlying)
    130,000

  • Stock Option (Right to Buy)

    Exercise: $2.83Exp: 2027-07-06→ Common Stock (130,000 underlying)
    130,000

  • Stock Option (Right to Buy)

    Exercise: $4.28Exp: 2028-07-12→ Common Stock (220,000 underlying)
    220,000
Footnotes (6)
  • [F1]One-quarter of such options shall vest on July 5, 2023, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 5, 2023.
  • [F2]One-quarter of such options vested on July 1, 2022, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2022.
  • [F3]All of such options are presently exercisable.
  • [F4]One-quarter of such options vested on July 12, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 12, 2019.
  • [F5]One-quarter of such options vested on July 1, 2020 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2020.
  • [F6]One-quarter of such options vested on July 2, 2021 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 2, 2021.

Documents

1 file

Issuer

MEI Pharma, Inc.

CIK 0001262104

→
Entity typeother

Related Parties

1
  • filerCIK 0001604256

Filing Metadata

Form type
4
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 4:22 PM ET
Size
16.2 KB
View on SEC.gov